Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA Damage and Cancer Immunotherapy: A STING in the Tale
Timo Reisländer, Florian J. Groelly, Madalena Tarsounas
Molecular Cell (2020) Vol. 80, Iss. 1, pp. 21-28
Open Access | Times Cited: 240

Showing 26-50 of 240 citing articles:

Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
Amirali B. Bukhari, Gordon K. Chan, Armin M. Gamper
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 40
Metal ions and nanometallic materials in antitumor immunity: Function, application, and perspective
Feiyang Shen, Yan Fang, Yijia Wu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 39
Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage
Liu‐Gen Li, Xing‐Chun Peng, Tingting Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Targeting DNA Damage and Repair Machinery via Delivering WEE1 Inhibitor and Platinum (IV) Prodrugs to Stimulate STING Pathway for Maximizing Chemo‐Immunotherapy in Bladder Cancer
Wenkuan Wang, Feiya Yang, Lingpu Zhang, et al.
Advanced Materials (2023) Vol. 36, Iss. 1
Closed Access | Times Cited: 29
Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control
Kyle Concannon, Benjamin B. Morris, Carl M. Gay, et al.
Molecular Cell (2023) Vol. 83, Iss. 5, pp. 660-680
Open Access | Times Cited: 27
Programmed initiation and enhancement of cGAS/STING pathway for tumour immunotherapy via tailor‐designed ZnFe2O4‐based nanosystem
Jing Yang, Yuping He, Meng Zhang, et al.
Exploration (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 24
Nanovaccines: An effective therapeutic approach for cancer therapy
Sangiliyandi Gurunathan, Thangaraj Pratheep, Lin Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115992-115992
Open Access | Times Cited: 24
GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer
Yao Long, Jiaxing Guo, Jielin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 22
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance
Petar-Bogomil Kanev, Aleksandar Atemin, Stoyno Stoynov, et al.
Seminars in Oncology (2023) Vol. 51, Iss. 1-2, pp. 2-18
Open Access | Times Cited: 22
A Trisulfide Bond Containing Biodegradable Polymer Delivering Pt(IV) Prodrugs to Deplete Glutathione and Donate H2S to Boost Chemotherapy and Antitumor Immunity
Xinyi Li, Jing Cai, Hanchen Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 11, pp. 7852-7867
Closed Access | Times Cited: 11
Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy
Yaxin Wang, Yunmeng Liu, Jincheng Zhang, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 51-76
Closed Access | Times Cited: 10
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
Eleonora Ghisoni, Matteo Morotti, Apostolos Sarivalasis, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 10
Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities
Xinan Wang, Giuseppe Lamberti, Alessandro Di Federico, et al.
Annals of Oncology (2024) Vol. 35, Iss. 6, pp. 508-522
Closed Access | Times Cited: 9
Platinum(IV)-Backboned Polymer Prodrug-Functionalized Manganese Oxide Nanoparticles for Enhanced Lung Cancer Chemoimmunotherapy via Amplifying Stimulator of Interferon Genes Activation
Li Liu, Shengxiang Fu, Haojie Gu, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Genotoxic stress and viral infection induce transient expression of APOBEC3A and pro-inflammatory genes through two distinct pathways
Sunwoo Oh, Elodie Bournique, Danae Bowen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 48
CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors
Zhiwen Shi, Jianfeng Shen, Junjun Qiu, et al.
Theranostics (2021) Vol. 11, Iss. 15, pp. 7175-7187
Open Access | Times Cited: 44
Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics
Jian Gao, Zhigui Wu, Mingxia Zhao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 149-166
Open Access | Times Cited: 44
Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies
Caroline Molinaro, Alain Martoriati, Katia Cailliau
Cancers (2021) Vol. 13, Iss. 15, pp. 3819-3819
Open Access | Times Cited: 42
DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients
Hitesh Vasiyani, Minal Mane, Khushboo Rana, et al.
APOPTOSIS (2022) Vol. 27, Iss. 11-12, pp. 961-978
Closed Access | Times Cited: 34
Targeting STING for cancer immunotherapy: From mechanisms to translation
Ruilei Huang, Qian Ning, Jihui Zhao, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109304-109304
Closed Access | Times Cited: 33
IFN-γ activates the tumor cell-intrinsic STING pathway through the induction of DNA damage and cytosolic dsDNA formation
Hui Xiong, Yu Xi, Zhiwei Yuan, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 31
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC
Kun Li, Yihang Gong, Dongbo Qiu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 8, pp. e004006-e004006
Open Access | Times Cited: 30
PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors
Anna D. Staniszewska, Joshua Armenia, Matthew King, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity
Hanfeng Wang, Fan Yang, Weihao Chen, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 28
The Role of cGAS-STING in Age-Related Diseases from Mechanisms to Therapies
Weitao Zheng, Dechao Feng, Xingyu Xiong, et al.
Aging and Disease (2023)
Open Access | Times Cited: 19

Scroll to top